| 000 | 01555 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514015258.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLutgens, E | |
| 245 | 0 | 0 |
_aTransforming growth factor-beta: a local or systemic mediator of plaque stability? _h[electronic resource] |
| 260 |
_bCirculation research _cNov 2001 |
||
| 300 |
_a853-5 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoproteins E _xdeficiency |
| 650 | 0 | 4 |
_aArteriosclerosis _xcomplications |
| 650 | 0 | 4 |
_aCD40 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aCD40 Ligand _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fc Fragments _xgenetics |
| 650 | 0 | 4 |
_aInflammation _xcomplications |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type II |
| 650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xantagonists & inhibitors |
| 700 | 1 | _aDaemen, M J | |
| 773 | 0 |
_tCirculation research _gvol. 89 _gno. 10 _gp. 853-5 |
|
| 999 |
_c11616884 _d11616884 |
||